VWA9
| Gene Symbol | VWA9 |
|---|---|
| Entrez Gene | 81556 |
| Alt Symbol | C15orf44 |
| Species | Human |
| Gene Type | protein-coding |
| Description | von Willebrand factor A domain containing 9 |
| Other Description | UPF0464 protein C15orf44|von Willebrand factor A domain-containing protein 9 |
| Swissprots | B4DDI6 Q49AH8 Q96HX5 Q96SY0 Q9H0S5 B4DVD5 |
| Accessions | EAW77737 EAW77738 Q96SY0 AA745705 AK027475 BAB55140 AK293207 BAG56747 AK296134 BAG58878 AK301033 BAG62647 AK301222 BAG62795 AK301742 BAG63205 AK310857 AL136662 CAB66597 AM392914 CAL37792 BC007991 AAH07991 BC037823 AAH37823 BM558754 BP315446 CA414283 DC298728 DC313962 DC316545 DC376467 DC384988 XM_006720708 XP_006720771 XM_006720709 XP_006720772 XM_006720711 XP_006720774 XM_011522101 XP_011520403 NM_030800 NM_001136043 NP_001129515 NM_001207058 NP_001193987 NM_001207059 NP_001193988 NR_045104 NR_045105 NR_045106 NR_045901 |
| Tissue Specificity | Strongly expressed in numerous cancer cells compared with their non-cancerous counterparts (lung, prostate, colon, stomach and skin). {ECO:0000269|PubMed:19160420}. |
VWA9 / C15orf44 Antibody Blocking Peptide - LS-E661 from LifeSpan Bioscience
|
||||||||||
CO044-Antibody-C-term-Blocking-peptide - BP11005b from Abgent, a WuXi AppTec company
|
||||||||||
C15orf44 fusion protein - ag19792 from Proteintech Group
|
||||||||||
C15orf44 fusion protein - ag19785 from Proteintech Group
|
||||||||||
Recombinant Human VWA9 - VWA9-1337H from Creative Biomart
|
||||||||||
Recombinant Human UPF0464 protein C15orf44(C15orf44) - CSB-YP847227HU CSB-EP847227HU CSB-BP847227HU CSB-MP847227HU from Cusabio
|
||||||||||
VWA9 Recombinant Protein Antigen - NBP1-90525PEP from Novus Biologicals
|
||||||||||
VWA9 Protein - NBP1-90524PEP from Novus Biologicals
|
||||||||||
VWA9 Peptide, Human - M34GP17366H from Creative Peptides
|